Antinuclear antibodies, apoptotic factors sFas and sFasL, and chemokines CXCL8, CXCL10, and CCL20 as prognostic biomarkers in multiple sclerosis

Josip Sremec, Jelena Košćak Lukač, Zurap Raifi, Koraljka Bačić Baronica, Nada Tomić Sremec, Berislav Ruška, Sanja Tomasović

Open source

DOI: 10.1016/j.msard.2026.107292
Published: 2026-08
Container: Multiple Sclerosis and Related Disorders
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.msard.2026.107292,
  title = {Antinuclear antibodies, apoptotic factors sFas and sFasL, and chemokines CXCL8, CXCL10, and CCL20 as prognostic biomarkers in multiple sclerosis},
  author = {Josip Sremec and Jelena Košćak Lukač and Zurap Raifi and Koraljka Bačić Baronica and Nada Tomić Sremec and Berislav Ruška and Sanja Tomasović},
  year = {2026},
  journal = {Multiple Sclerosis and Related Disorders},
  doi = {10.1016/j.msard.2026.107292},
  url = {https://doi.org/10.1016/j.msard.2026.107292}
}

RIS

TY  - JOUR
TI  - Antinuclear antibodies, apoptotic factors sFas and sFasL, and chemokines CXCL8, CXCL10, and CCL20 as prognostic biomarkers in multiple sclerosis
AU  - Josip Sremec
AU  - Jelena Košćak Lukač
AU  - Zurap Raifi
AU  - Koraljka Bačić Baronica
AU  - Nada Tomić Sremec
AU  - Berislav Ruška
AU  - Sanja Tomasović
PY  - 2026
JO  - Multiple Sclerosis and Related Disorders
DO  - 10.1016/j.msard.2026.107292
UR  - https://doi.org/10.1016/j.msard.2026.107292
ER  -

APA

Sremec, J., Lukač, J. K., Raifi, Z., Baronica, K. B., Sremec, N. T., Ruška, B., & Tomasović, S. (2026). Antinuclear antibodies, apoptotic factors sFas and sFasL, and chemokines CXCL8, CXCL10, and CCL20 as prognostic biomarkers in multiple sclerosis. Multiple Sclerosis and Related Disorders. https://doi.org/10.1016/j.msard.2026.107292

Source records

crossref · retrieved 2026-09-25T16:25:20.996Z